Illumina and Deerfield Management partner to accelerate drug development

First-of-its-kind partnership will identify drug targets and accelerate novel therapy development using genomics and artificial intelligence SAN DIEGO, May 5, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Deerfield…

Click here to view original post